Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04444284
What this trial is testing

Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children

Who this might be right for
Respiratory Syncytial Virus Infections
Meissa Vaccines, Inc. 34
Early research (Phase 1)Active Not RecruitingNCT06645665
What this trial is testing

Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd 240
Not applicableUnknownNCT05348616
What this trial is testing

Impact of the Covid-19 on RSV

Who this might be right for
RhinovirusRSV Infection
Hospices Civils de Lyon 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984094
What this trial is testing

Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
RSV InfectionHuman Metapneumovirus InfectionParainfluenza Infection
Clover Biopharmaceuticals AUS Pty 612
Early research (Phase 1)Study completedNCT04540627
What this trial is testing

Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV

Who this might be right for
Healthy Adult Participants
mAbxience Research S.L. 56
Large-scale testing (Phase 3)Ended earlyNCT04980391
What this trial is testing

A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 384
Early research (Phase 1)Study completedNCT01905215
What this trial is testing

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 128
Not applicableStudy completedNCT02016690
What this trial is testing

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie 312
Not applicableStudy completedNCT06743750
What this trial is testing

Comparison Between Different Sampling Sites for Detection of Respiratory Viruses

Who this might be right for
Respiratory Tract Infection Viral
Insel Gruppe AG, University Hospital Bern 501
Very early researchLooking for participantsNCT07106918
What this trial is testing

A Clinical Trial of SIBP-A16 Injection in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
Shanghai Institute Of Biological Products 140
Early research (Phase 1)Active Not RecruitingNCT04896853
What this trial is testing

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeInfluenza AMetapneumovirus Pneumonia+1 more
NextCell Pharma Ab 9
Testing effectiveness (Phase 2)Study completedNCT03691623
What this trial is testing

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 179
Not applicableLooking for participantsNCT06881056
What this trial is testing

Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia

Who this might be right for
Respiratory Syncytial Virus (RSV)
West China Second University Hospital 90
Not applicableStudy completedNCT03757429
What this trial is testing

Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus

Who this might be right for
Respiratory Tract InfectionsRespiratory Syncytial Virus Infections
Uppsala University 31
Testing effectiveness (Phase 2)Ended earlyNCT03715023
What this trial is testing

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

Who this might be right for
Respiratory Syncytial Virus Infections
Pulmocide Ltd 5
Not applicableEnded earlyNCT04431050
What this trial is testing

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens

Who this might be right for
Human InfluenzaRespiratory Syncytial Virus InfectionsRhinoviral Infections+3 more
Imperial College London 6
Early research (Phase 1)Study completedNCT06847464
What this trial is testing

A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

Who this might be right for
RSV InfectionDrug Drug Interaction (DDI)
Enanta Pharmaceuticals, Inc 48
Testing effectiveness (Phase 2)Study completedNCT04071158
What this trial is testing

A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Who this might be right for
Respiratory Tract Infection
Pfizer 713
Post-approval studies (Phase 4)Study completedNCT02571517
What this trial is testing

Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis

Who this might be right for
Bronchiolitis, Viral
Fundació Sant Joan de Déu 94
Testing effectiveness (Phase 2)Study completedNCT03026348
What this trial is testing

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

Who this might be right for
Respiratory Syncytial Viruses
Novavax 300
Next Page